BR0110396A - Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia - Google Patents
Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapiaInfo
- Publication number
- BR0110396A BR0110396A BR0110396-2A BR0110396A BR0110396A BR 0110396 A BR0110396 A BR 0110396A BR 0110396 A BR0110396 A BR 0110396A BR 0110396 A BR0110396 A BR 0110396A
- Authority
- BR
- Brazil
- Prior art keywords
- radiotherapy
- methods
- induced alopecia
- prevent
- treat chemotherapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"MéTODOS PARA PREVENIR E TRATAR ALOPECIA INDUZIDA POR QUIMIOTERAPIA OU RADIOTERAPIA". A invenção fornece um método para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia pela administração a uma espécie de mamífero que necessita do mesmo de uma quantidade terapeuticamente eficaz de um composto de fórmula (I) ou (II) ou um sal farmaceuticamente aceitável dos mesmos.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20006800P | 2000-04-27 | 2000-04-27 | |
US61662700A | 2000-07-26 | 2000-07-26 | |
US09/727,957 US6515004B1 (en) | 1999-12-15 | 2000-12-01 | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
US09/746,060 US6414156B2 (en) | 1998-10-21 | 2000-12-22 | Process for preparing azacycloalkanoylaminothiazoles |
PCT/US2001/013818 WO2001080813A2 (en) | 2000-04-27 | 2001-04-27 | Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0110396A true BR0110396A (pt) | 2003-07-01 |
Family
ID=27498367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0110396-2A BR0110396A (pt) | 2000-04-27 | 2001-04-27 | Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia |
Country Status (8)
Country | Link |
---|---|
US (1) | US6534531B2 (pt) |
EP (1) | EP1282419A2 (pt) |
JP (1) | JP2003531158A (pt) |
CN (1) | CN1440284A (pt) |
AU (2) | AU5576601A (pt) |
BR (1) | BR0110396A (pt) |
CA (1) | CA2407507A1 (pt) |
WO (1) | WO2001080813A2 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6414156B2 (en) | 1998-10-21 | 2002-07-02 | Bristol-Myers Squibb Company | Process for preparing azacycloalkanoylaminothiazoles |
CN100357283C (zh) * | 2002-04-02 | 2007-12-26 | 中国科学院上海药物研究所 | 一类甲硫氨酰氨肽酶抑制剂 |
DE10300124A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Ag | Verfahren zur Herstellung von Arylalkinen |
CA2573999A1 (en) * | 2004-07-16 | 2006-04-06 | Sunesis Pharmaceuticals, Inc. | Thienopyrimidines useful as aurora kinase inhibitors |
JP4689393B2 (ja) * | 2005-07-29 | 2011-05-25 | 株式会社資生堂 | 毛髪はり・こし改善剤および毛髪用化粧料 |
KR20080030031A (ko) * | 2005-07-29 | 2008-04-03 | 가부시키가이샤 시세이도 | 모발 생기·탄력 개선제 및 모발용 화장료 |
JP4646739B2 (ja) * | 2005-08-29 | 2011-03-09 | 株式会社資生堂 | 毛髪はり・こし改善剤および毛髪用化粧料 |
CN101495148B (zh) * | 2005-10-21 | 2012-12-19 | 万能药生物有限公司 | 包括至少一种抗癌药和至少一种聚合物的药物组合物 |
EP2044066A2 (en) * | 2006-06-06 | 2009-04-08 | Bristol-Myers Squibb Company | Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide |
US20080188524A1 (en) * | 2006-10-25 | 2008-08-07 | Martin Augustin | Methods of treating pain |
TW200922564A (en) * | 2007-09-10 | 2009-06-01 | Curis Inc | CDK inhibitors containing a zinc binding moiety |
WO2010075542A1 (en) | 2008-12-23 | 2010-07-01 | Curis, Inc. | Cdk inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
US6040321A (en) | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
US6414156B2 (en) * | 1998-10-21 | 2002-07-02 | Bristol-Myers Squibb Company | Process for preparing azacycloalkanoylaminothiazoles |
US6214852B1 (en) * | 1998-10-21 | 2001-04-10 | Bristol-Myers Squibb Company | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
GB9904932D0 (en) * | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy |
-
2001
- 2001-04-26 US US09/842,595 patent/US6534531B2/en not_active Expired - Lifetime
- 2001-04-27 CN CN01808658A patent/CN1440284A/zh active Pending
- 2001-04-27 AU AU5576601A patent/AU5576601A/xx active Pending
- 2001-04-27 EP EP01928966A patent/EP1282419A2/en not_active Withdrawn
- 2001-04-27 BR BR0110396-2A patent/BR0110396A/pt not_active IP Right Cessation
- 2001-04-27 CA CA002407507A patent/CA2407507A1/en not_active Abandoned
- 2001-04-27 AU AU2001255766A patent/AU2001255766B2/en not_active Ceased
- 2001-04-27 JP JP2001577914A patent/JP2003531158A/ja active Pending
- 2001-04-27 WO PCT/US2001/013818 patent/WO2001080813A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1282419A2 (en) | 2003-02-12 |
AU5576601A (en) | 2001-11-07 |
CA2407507A1 (en) | 2001-11-01 |
US20020061915A1 (en) | 2002-05-23 |
WO2001080813A2 (en) | 2001-11-01 |
JP2003531158A (ja) | 2003-10-21 |
US6534531B2 (en) | 2003-03-18 |
CN1440284A (zh) | 2003-09-03 |
WO2001080813A3 (en) | 2002-02-07 |
AU2001255766B2 (en) | 2004-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1169060T3 (da) | Natriumkanalblokkerpræparater og anvendelse deraf | |
BR0109517A (pt) | métodos e composições sinérgicas para tratar o cáncer | |
LU92642I2 (fr) | Pomalidomide et ses sels, solvates, hydrates ou stéréoisomères pharmaceutiquement acceptables qui endérivent (Imnovid) | |
CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
BR0110420A (pt) | Agonistas muscarìnicos | |
EA200500893A1 (ru) | Трициклические соединения, представляющие собой ингибиторы протеинкиназ, для увеличения эффективности противоопухолевых агентов и лучевой терапии | |
BRPI0413255A (pt) | uso de uma combinação de um inibidor de quinase do receptor do fator de crescimento epidérmico e agentes citotóxicos para tratamento e inibição do cáncer | |
BRPI0411241A (pt) | agentes terapêuticos úteis para o tratamento de dor | |
BR9809115A (pt) | Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt | |
BR9810911A (pt) | Composto, e, processo para tratar câncer em um mamìfero | |
BR0110396A (pt) | Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia | |
DE69940951D1 (de) | Nd wachstumshemmende mittel | |
BR0207316A (pt) | Derivados de epotilona para o tratamento de tumores refratários | |
BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
DK0699439T3 (da) | Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer | |
DK0583421T3 (da) | Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse | |
BR0009524A (pt) | Uso de um composto, e, composição farmacêutica ou veterinaria | |
BR0311491A (pt) | Composto, composição farmacêutica, uso de um composto, e, método terapêutico para tratar câncer em um mamìfero | |
BR9915390A (pt) | Tratamento de tumores através de administração de compostos que liberam harmÈnio de crescimento e seus antagonistas | |
EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
PT986393E (pt) | Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro | |
BR0316054A (pt) | Compostos para tratamento de dependência e privação de tabaco | |
RU2007143434A (ru) | 4-анилино-3-хинолинкарбонитрилы, подходящие для лечения раковых заболеваний | |
ATE302011T1 (de) | PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009. |